Isolation of a novel gene mutated in Wiskott-Aldrich syndrome

Ammann, 1989, Disorders of the T-cell system, 257 Brochstein, 1991, Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome, J. Pediatr., 119, 907, 10.1016/S0022-3476(05)83041-0 Cicchetti, 1992, Identification of a protein that binds to the SH3 region of AN and is similar to Bcr and GAP-Rho, Science, 257, 803, 10.1126/science.1379745 Creighton, 1984, Proteins, 242 de Saint Basile, 1989, Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome, Lancet, ii, 1319, 10.1016/S0140-6736(89)91920-X Dingwall, 1991, Nuclear targeting sequences—a consensus?, Trends Biochem. Sci., 16, 478, 10.1016/0968-0004(91)90184-W Donner, 1988, Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome, Blood, 72, 1849, 10.1182/blood.V72.6.1849.1849 Dreyfuss, 1993, hnRNP proteins and the biogenesis of mRNA, Annu. Rev. Biochem., 62, 289, 10.1146/annurev.bi.62.070193.001445 Fearon, 1988, Carrier detection in the Wiskott-Aldrich syndrome, Blood, 72, 1735, 10.1182/blood.V72.5.1735.1735 Gealy, 1980, Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich syndrome carrier, Lancet, i, 63, 10.1016/S0140-6736(80)90492-4 Geraghty, 1993, The isolation of cDNAs from OATL1 at Xp 11.2 using a 480-kb YAC, Genomics, 16, 440, 10.1006/geno.1993.1208 Gerber, 1994, Transcriptional activation modulated by homopolymeric glutamine and proline stretches, Science, 263, 808, 10.1126/science.8303297 Gerster, 1990, The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription, EMBO J., 9, 1635, 10.1002/j.1460-2075.1990.tb08283.x Gill, 1987, Mutants of GAL4 protein altered in an activation function, Cell, 51, 121, 10.1016/0092-8674(87)90016-X Goodship, 1991, Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe, J. Pediatr., 119, 907 Green, 1990, Chromosomal region of the cystic fibrosis gene in yeast artificial chromosomes: a model for human genome mapping, Science, 250, 94, 10.1126/science.2218515 Greer, 1989, Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation, Biochem. Cell Biol., 67, 503, 10.1139/o89-081 Greer, 1989, X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect, Genomics, 4, 60, 10.1016/0888-7543(89)90315-7 Greer, 1990, Linkage relationships of the Wiskott-Aldrich syndrome to 10 loci in the pericentromeric region of the human X chromosome, Genomics, 6, 568, 10.1016/0888-7543(90)90489-H Greer, 1992, The Wiskott-Aldrich syndrome: refinement of the localization on Xp and identification of another closely linked marker locus, OATL1, Hum. Genet., 88, 453, 10.1007/BF00215681 Higgins, 1991, Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome, J. Biol. Chem., 266, 6280, 10.1016/S0021-9258(18)38115-8 Hope, 1986, Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast, Cell, 46, 885, 10.1016/0092-8674(86)90070-X Imagawa, 1991, Stringent integrity requirements for both transactivation and DNA-binding in a trans-activator, Oct3, Nucl. Acids Res., 19, 4503, 10.1093/nar/19.16.4503 Kim, 1994, Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation, 91, 4170 Kozak, 1987, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs, Nucl. Acids Res., 15, 8125, 10.1093/nar/15.20.8125 Kwan, 1988, Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers, Genomics, 3, 39, 10.1016/0888-7543(88)90156-5 Kwan, 1991, Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3, Genomics, 10, 29, 10.1016/0888-7543(91)90480-3 Kyte, 1982, A simple method for displaying the hydropathic character of a protein, J. Mol. Biol., 157, 105, 10.1016/0022-2836(82)90515-0 Lafreniere, 1991, Physical mapping of 60 DNA markers in the p21.1--q21.3 region of the human X chromosome, Genomics, 11, 352, 10.1016/0888-7543(91)90143-3 Lovett, 1991, Direct selection: a method for the isolation of cDNAs encoded by large genomic regions, 88, 9628 Ma, 1987, Deletion analysis of GAL4 defines two transcriptional activating segments, Cell, 48, 847, 10.1016/0092-8674(87)90081-X Majerus, 1987, Platelets, 689 Miyamoto, 1988, Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements, Cell, 54, 903, 10.1016/S0092-8674(88)91307-4 Molina, 1992, T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome, J. Exp. Med., 176, 867, 10.1084/jem.176.3.867 Molina, 1993, T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses, J. Immunol., 151, 4383, 10.4049/jimmunol.151.8.4383 Morgan, 1992, The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes, Nucl. Acids Res., 20, 5173, 10.1093/nar/20.19.5173 Nizetic, 1991, Construction, arraying, and high-density screening of large insert libraries of human chromosomes X and 21: their potential use as reference libraries, Blood, 77, 2677 Notarangelo, 1991, Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS, Hum. Genet., 88, 237, 10.1007/BF00206081 Ochs, 1980, The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets, Blood, 55, 243, 10.1182/blood.V55.2.243.243 Okamoto, 1990, A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells, Cell, 60, 461, 10.1016/0092-8674(90)90597-8 Oppenheim, 1970, Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome, J. Immunol., 104, 835, 10.4049/jimmunol.104.4.835 Peacocke, 1987, Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome, 84, 3430 Pei, 1991, An “attenuator domain” is sandwiched by two distinct transactivation domains in the transcription factor C/EBP, Mol. Cell. Biol., 11, 1480, 10.1128/MCB.11.3.1480 Piller, 1991, Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome, J. Exp. Med., 173, 1501, 10.1084/jem.173.6.1501 Rambaldi, 1994, A prolinerich transcriptional activation domain in murine HOXD-4 (HOX-4.2), Nucl. Acids Res., 22, 376, 10.1093/nar/22.3.376 Remold-O'Donnell, 1984, Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome, J. Exp. Med., 159, 1705, 10.1084/jem.159.6.1705 Remold-O'Donnell, 1987, Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome, Blood, 70, 104, 10.1182/blood.V70.1.104.104 Riley, 1990, A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones, Nucl. Acids Res., 18, 2887, 10.1093/nar/18.10.2887 Santoro, 1988, A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs, Nature, 334, 218, 10.1038/334218a0 Schlessinger, 1993, 64, 163 Shelley, 1989, Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome, 86, 2819 Simon, 1992, Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome, J. Clin. Invest., 90, 1396, 10.1172/JCI116006 Simpson, 1994, Frameshift mutations in the v-src gene of avian sarcoma virus act in cis to specifically reduce v-src mRNA levels, Mol. Cell. Biol., 14, 1835, 10.1128/MCB.14.3.1835 Standen, 1986, Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome, Q. J. Med., 59, 401 Triezenberg, 1988, Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression, Genes Dev., 2, 718, 10.1101/gad.2.6.718 Yu, 1994, Structural basis for the binding of proline-rich peptides to SH3 domains, Cell, 76, 933, 10.1016/0092-8674(94)90367-0